TY - JOUR
T1 - Controlling the seedbeds of tuberculosis
T2 - Diagnosis and treatment of tuberculosis infection
AU - Rangaka, Molebogeng X.
AU - Cavalcante, Solange C.
AU - Marais, Ben J.
AU - Thim, Sok
AU - Martinson, Neil A.
AU - Swaminathan, Soumya
AU - Chaisson, Richard E.
N1 - Funding Information:
We thank Ed Nardell for his review and the important comments he contributed during drafting, and Carly Rodriguez for coordination and research assistance in the preparation of this manuscript. MXR was supported by a University College London Excellence Fellowship and reports grants from the National Institute for Health Research University College London Hospitals Biomedical Research Centre. NAM reports grants from the US National Institutes of Health ( R01 HD064354-03 and R01 DA030276-01A1 ) and the Medical Research Council Soweto Matlosana Center for HIV/AIDS and TB Research, and NAM and REC report grants from the US Centers for Disease Control and Prevention (2000-2009-32589). REC reports grants from the US National Institutes of Health (P30-AI-094189).
Publisher Copyright:
© 2015 Elsevier Ltd.
PY - 2015/12/5
Y1 - 2015/12/5
N2 - The billions of people with latent tuberculosis infection serve as the seedbeds for future cases of active tuberculosis. Virtually all episodes of tuberculosis disease are preceded by a period of asymptomatic Mycobacterium tuberculosis infection; therefore, identifying infected individuals most likely to progress to disease and treating such subclinical infections to prevent future disease provides a crucial opportunity to interrupt tuberculosis transmission and reduce the global burden of tuberculosis disease. Programmes focusing on single strategies rather than comprehensive programmes that deliver an integrated arsenal for tuberculosis control might continue to struggle. Tuberculosis preventive therapy is a poorly used method that is essential for controlling the reservoirs of disease that drive the epidemic. Comprehensive control strategies that combine preventive therapy for the most high-risk populations and communities with improved case-finding and treatment, control of transmission, and health systems strengthening could ultimately lead to worldwide tuberculosis elimination. In this Series paper we outline challenges to implementation of preventive therapy and provide pragmatic suggestions for overcoming them. We further advocate for tuberculosis preventive therapy as the core of a renewed worldwide focus to implement a comprehensive epidemic control strategy that would reduce new tuberculosis cases to elimination targets. This strategy would be underpinned by accelerated research to further understand the biology of subclinical tuberculosis infections, develop novel diagnostics and drug regimens specifically for subclinical tuberculosis infection, strengthen health systems and community engagement, and enhance sustainable large scale implementation of preventive therapy programmes.
AB - The billions of people with latent tuberculosis infection serve as the seedbeds for future cases of active tuberculosis. Virtually all episodes of tuberculosis disease are preceded by a period of asymptomatic Mycobacterium tuberculosis infection; therefore, identifying infected individuals most likely to progress to disease and treating such subclinical infections to prevent future disease provides a crucial opportunity to interrupt tuberculosis transmission and reduce the global burden of tuberculosis disease. Programmes focusing on single strategies rather than comprehensive programmes that deliver an integrated arsenal for tuberculosis control might continue to struggle. Tuberculosis preventive therapy is a poorly used method that is essential for controlling the reservoirs of disease that drive the epidemic. Comprehensive control strategies that combine preventive therapy for the most high-risk populations and communities with improved case-finding and treatment, control of transmission, and health systems strengthening could ultimately lead to worldwide tuberculosis elimination. In this Series paper we outline challenges to implementation of preventive therapy and provide pragmatic suggestions for overcoming them. We further advocate for tuberculosis preventive therapy as the core of a renewed worldwide focus to implement a comprehensive epidemic control strategy that would reduce new tuberculosis cases to elimination targets. This strategy would be underpinned by accelerated research to further understand the biology of subclinical tuberculosis infections, develop novel diagnostics and drug regimens specifically for subclinical tuberculosis infection, strengthen health systems and community engagement, and enhance sustainable large scale implementation of preventive therapy programmes.
UR - http://www.scopus.com/inward/record.url?scp=84949487910&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949487910&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(15)00323-2
DO - 10.1016/S0140-6736(15)00323-2
M3 - Review article
C2 - 26515679
AN - SCOPUS:84949487910
SN - 0140-6736
VL - 386
SP - 2344
EP - 2353
JO - The Lancet
JF - The Lancet
IS - 10010
ER -